Azo compounds
Chem-Impex International, Inc. Dibenzyl azodicarboxylate | MFCD00016737 | 5G
Dibenzyl azodicarboxylate, MFCD00016737, 5G
Sigma Aldrich Fine Chemicals Biosciences Naphthol Blue Black BioReagent, suitable for electrophoresis | 1064-48-8 | MFCD00004017 | 25G
Naphthol Blue Black BioReagent, suitable for electrophoresis | Mol Wt: 616.49 | 1064-48-8 | MFCD00004017 | 25G
Ambeed N1 N1 N2 N2Tetramethyldiazene1
N1,N1,N2,N2-Tetramethyldiazene-1,2-dicarboxamide, 10465-78-8, 97%
Ambeed N1 N1 N2 N2Tetramethyldiazene1
N1,N1,N2,N2-Tetramethyldiazene-1,2-dicarboxamide, 10465-78-8, 97%
Selleck Chemical LLC APG-2449-E1508-1G
APG-2449 is an orally active inhibitor of ALK/ROS1/FAK APG-2449 exerts potent and durable antitumor activity in human non-small-cell lung cancer (NSCLC) and ovarian tumor models
Selleck Chemical LLC APG-2449-E1508-25MG
APG-2449 is an orally active inhibitor of ALK/ROS1/FAK APG-2449 exerts potent and durable antitumor activity in human non-small-cell lung cancer (NSCLC) and ovarian tumor models
Apexbio Technology LLC KW 2449 1000669-72-6 50mg
KW 2449 (CAS 1000669-72-6) is a multi-targeted kinase inhibitor with potent activity against FLT3 (IC50 6 6 nM) ABL (14 nM) Aurora kinases (4 nM) and FGFR (48 nM) It inhibits both wild-type and T315I-mutated ABL tyrosine kinase In vitro KW 2449 disrupts proliferation through modulation of distinct signaling pathways it downregulates FLT3/STAT5 phosphorylation and induces G1-phase arrest and apoptosis in FLT3-mutated leukemia cells while promoting G2/M arrest via reduced histone H3 phosphorylation in FLT3 wild-type cells KW 2449 is applied in research investigating kinase-driven leukemias and resistance mechanisms to targeted therapies
Apexbio Technology LLC KW 2449 1000669-72-6 200mg
KW 2449 (CAS 1000669-72-6) is a multi-targeted kinase inhibitor with potent activity against FLT3 (IC50 6 6 nM) ABL (14 nM) Aurora kinases (4 nM) and FGFR (48 nM) It inhibits both wild-type and T315I-mutated ABL tyrosine kinase In vitro KW 2449 disrupts proliferation through modulation of distinct signaling pathways it downregulates FLT3/STAT5 phosphorylation and induces G1-phase arrest and apoptosis in FLT3-mutated leukemia cells while promoting G2/M arrest via reduced histone H3 phosphorylation in FLT3 wild-type cells KW 2449 is applied in research investigating kinase-driven leukemias and resistance mechanisms to targeted therapies
Sigma Aldrich Fine Chemicals Biosciences Naphthol Blue Black Dye content 80 % | 1064-48-8 | MFCD00004017 | 100G
Naphthol Blue Black Dye content 80 % | Mol Wt: 616.49 | 1064-48-8 | MFCD00004017 | 100G
Medchemexpress LLC Apg-2449 | 2196186-84-0 | 98.9% | 640.24 g/mol | C33H42ClN5O4S | 10 MG
APG-2449 is an orally active small-molecule inhibitor that targets focal adhesion kinase (FAK) and receptor tyrosine kinases including ALK and ROS1. It is provided for research use only and is characterized by defined physicochemical properties and supporting analytical documentation.
- Inhibits FAK, ALK, and ROS1 kinases.
- Demonstrates oral activity in preclinical models.
- High purity suitable for research applications.
- Supplied in small-scale packaging for dosing and formulation studies.
- Characterized by molecular formula C33H42ClN5O4S and molecular weight 640.24 g/mol.